Emergent Biosolutions reported $2.87B in Assets for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Acadia Pharmaceuticals ACAD:US $ 717.67M 6.76M
Akebia Therapeutics AKBA:US $ 602.27M 9.6M
ALKERMES ALKS:US $ 1995.43M 57.86M
Alnylam Pharmaceuticals ALNY:US $ 3472.31M 37.12M
Amarin AMRN:US $ 1035.8M 9.19M
Ani Pharmaceuticals ANIP:US $ 470.45M 9.7M
Biomarin Pharmaceutical BMRN:US $ 5977.48M 78.98M
Chimerix CMRX:US $ 133.4M 13.32M
Coherus Biosciences CHRS:US $ 741.73M 2.18M
Emergent Biosolutions EBS:US $ 2867.5M 47.7M
Exact Sciences EXAS:US $ 6654.44M 69.9M
Exelixis EXEL:US $ 2447.74M 80.47M
Flexion Therapeutics FLXN:US $ 217.93M 7.88M
Glaxosmithkline GSK:US $ 78689M 1678M
Heron Therapeutics HRTX:US $ 352.39M 51.86M
Immunogen IMGN:US $ 296.8M 4.64M
Intercept Pharmaceuticals ICPT:US $ 523.07M 0.15M
IONIS PHARMACEUT IONS:US $ 2415M 82.07M
Ironwood Pharmaceuticals IRWD:US $ 1079.37M 72.15M
JAZZ PHA JAZZ:US $ 12478.15M 734.84M
Lexicon Pharmaceuticals LXRX:US $ 172.33M 658K
Lonza Group LONN:SW 15.16B 732M
Moderna Inc MRNA:US 20.92B 4.77B
Myriad Genetics MYGN:US $ 1335.9M 24.4M
Nektar Therapeutics NKTR:US $ 1277.24M 94.11M
Neurocrine Biosciences NBIX:US $ 2017.3M 60.9M
Opko Health OPK:US $ 2417.64M 4.01M
Pacira Pharmaceuticals PCRX:US $ 1356M 30.17M
Ptc Therapeutics PTCT:US $ 2007.32M 51.34M
Sarepta Therapeutics SRPT:US $ 2662.22M 96.86M
Seattle Genetics SGEN:US $ 3977.88M 25.72M
Teva Pharmaceutical Industries TEVA:US $ 47851M 1344M
United Therapeutics UTHR:US $ 5048.9M 204M
Vanda Pharmaceuticals VNDA:US $ 579.77M 12.12M
Xoma XOMA:US $ 130.5M 5.25M